Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS

Frontiers in Cellular Neuroscience
Maria Teresa CarríMauro Cozzolino

Abstract

It is well known that mitochondrial damage (MD) is both the major contributor to oxidative stress (OS) (the condition arising from unbalance between production and removal of reactive oxygen species) and one of the major consequences of OS, because of the high dependance of mitochondrial function on redox-sensitive targets such as intact membranes. Conditions in which neuronal cells are not able to cope with MD and OS seem to lead or contribute to several neurodegenerative diseases including Amyotrophic Lateral Sclerosis (ALS), at least in the most studied superoxide dismutase 1 (SOD1)-linked genetic variant. As summarized in this review, new evidence indicates that MD and OS play a role also in non-SOD1 ALS and thus they may represent a target for therapy despite previous failures in clinical trials.

References

Sep 2, 2006·Proceedings of the National Academy of Sciences of the United States of America·Alberto FerriMaria Teresa Carrì
Jun 24, 2009·BMC Neuroscience·Manoj Kumar JaiswalBernhard U Keller
Sep 22, 2009·Journal of Neurochemistry·Claudia ColombritaAntonia Ratti
Aug 12, 2010·Human Molecular Genetics·Daryl A BoscoLawrence J Hayward
Aug 13, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ya-Fei XuLeonard Petrucelli
Aug 26, 2010·Proceedings of the National Academy of Sciences of the United States of America·Xiu ShanPhilip C Wong
Sep 11, 2010·Human Molecular Genetics·Alberto FerriMaria Teresa Carrì
Nov 17, 2010·Proceedings of the National Academy of Sciences of the United States of America·Quan LiTimothy M Miller
Feb 23, 2011·Antioxidants & Redox Signaling·Cristina Sánchez-RamosMaría Monsalve
Jul 13, 2011·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Yasuyuki HonjoKoji Kawakami
Aug 11, 2011·Progress in Neurobiology·Mauro Cozzolino, Maria Teresa Carrì
Feb 7, 2012·Neurochemistry International·Sarah J ParkerAnthony R White
Mar 15, 2012·Proceedings of the National Academy of Sciences of the United States of America·Stefania GuareschiPiera Pasinelli
Sep 12, 2012·Experimental Gerontology·Alexandra S Bause, Marcia C Haigis
Mar 5, 2013·The Journal of Clinical Investigation·Jessica A HallPere Puigserver
Mar 12, 2013·Human Molecular Genetics·Caroline VanceChristopher E Shaw
Mar 19, 2013·Neuron·Fernando BartolomeHelene Plun-Favreau
Mar 26, 2013·Neurobiology of Disease·Valeria GerbinoTilmann Achsel
Jun 26, 2013·Free Radical Biology & Medicine·Emanuele D'AmicoHiroshi Mitsumoto
Oct 5, 2013·Molecular Neurodegeneration·Desiree M BaronDaryl A Bosco
Feb 12, 2014·The Journal of Biological Chemistry·Carola StriblThomas Floss
Feb 27, 2014·Biochimica Et Biophysica Acta·Wenzhi TanDavide Trotti
Apr 29, 2014·Neuroscience Letters·N WeiduschatD C Shungu

❮ Previous
Next ❯

Citations

Aug 19, 2015·Neurobiology of Disease·Giovanni Manfredi, Hibiki Kawamata
Apr 12, 2016·Brain Research·Sonam Parakh, Julie D Atkin
Nov 26, 2015·Journal of Neuroinflammation·Carolin DahlkeCarsten Theiss
Oct 31, 2015·Neuropharmacology·Cinzia VolontéSusanna Amadio
May 1, 2016·Free Radical Biology & Medicine·Ana Popović-BijelićGoran Bačić
Aug 23, 2016·Biochemical and Biophysical Research Communications·Roland PataiLászló Siklós
Feb 8, 2018·Frontiers in Molecular Neuroscience·Timothy J TraceyShyuan T Ngo
Jan 13, 2018·Frontiers in Neuroscience·Wenting GuoLudo Van Den Bosch
Oct 11, 2017·Current Medicinal Chemistry·Ester TelloneSilvana Ficarra
Feb 12, 2020·International Journal of Sports Physiology and Performance·Michal BotekBarbora Sládečková
Dec 29, 2016·Reviews in the Neurosciences·Sonia EspositoClaudia Crosio
Mar 7, 2019·Frontiers in Molecular Neuroscience·Archana PrasadBasant K Patel
Jan 9, 2020·World Journal of Clinical Cases·Ming-Xuan Yang, Xue-Nong Chen
Dec 12, 2019·Neural Regeneration Research·Shuang-Xi ChenWei-Jiang Zhao
Mar 3, 2020·Frontiers in Physiology·Sandra Carrera-JuliáEraci Drehmer
Feb 26, 2020·Biomolecules·Trevor CroftSu-Ju Lin
May 13, 2020·International Journal of Molecular Sciences·Cristina AngeloniTullia Maraldi
Mar 18, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Efthimios DardiotisGeorgios M Hadjigeorgiou
May 1, 2020·Frontiers in Physiology·Chansik HongInsuk So
Dec 18, 2020·Frontiers in Cellular Neuroscience·Luke McAlaryNeil R Cashman
Nov 5, 2020·International Journal of Molecular Sciences·Alexander I KostyukDmitry S Bilan
Oct 8, 2021·Environmental Science and Pollution Research International·Rahul TripathiPravir Kumar

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.